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Abstract
Carotenoids, the most common fat-soluble plant pigments in nature, are beneficial 
to human health due to their strong antioxidant activities and abilities to prevent 
various diseases. Carotenoids have many geometrical isomers forms caused by E/Z-
isomerization at arbitrary sites within the multiple conjugated double bonds. Several 
studies have addressed that the bioavailability as well as the antioxidant, anticancer, and 
antiatherosclerotic activities of carotenoids varies among the isomers. In addition, those 
variations differ among carotenoids: Z-isomerization resulted in “positive” or “nega-
tive” effect for carotenoids bioavailability and functionality, for example, Z-isomers of 
lycopene are more bioavailable than the all-E-isomer, whereas the opposite is observed 
for β-carotene. Thus, to efficiently promote the beneficial effects of carotenoids by inges-
tion, it is important to have a good understanding of the impact of E/Z-isomerization on 
the corresponding functional changes. The objective of this contribution is to review the 
effects of carotenoid Z-isomerization on bioavailability and functionality and describe 
their differences among carotenoids.
Keywords: lycopene, β-carotene, astaxanthin, E/Z-isomer, bioavailability, antioxidant 
activity
1. Introduction
Carotenoids are the most common lipid-soluble pigments responsible for the colors of plants, 
animals, and microorganisms, and over 1100 different types of carotenoids have been charac-
terized so far [1, 2]. Carotenoids can be divided into the following two groups: (1) carotenes, 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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which are nonoxygenated molecules such as lycopene and β-carotene; (2) xanthophylls, which 
are oxygen-containing molecules such as astaxanthin and fucoxanthin (Figure 1) [3]. The daily 
consumption of carotenoid-rich foods would be beneficial for human health because of their 
high antioxidant, anticancer, and antiatherosclerotic activities [4–6]. Because carotenoids con-
tain numerous conjugated double bonds, many kinds of geometrical isomers are theoretically 
possible (Figure 1C, E and F). In general, carotenoids in plants occur predominantly in the 
(all-E)-configuration, whereas the Z-isomers are present in the human body and processed foods 
in considerable quantity, for example, over 50% of total lycopene is present as the Z-isomers 
in serum and tissues [7–9]. Data from several studies have shown that the Z-isomerization of 
carotenoids induced changes in important properties, such as the bioavailability, antioxidant 
activity, and anticancer activity [10–13]. However, these outcomes vary depending on the type 
of carotenoid: there were cases where the beneficial effects of carotenoids increased or reduced 
by the Z-isomerization [10–15]. For example, Z-isomers of lycopene and astaxanthin have 
higher bioavailability than the all-E-isomers [12, 16], whereas Z-isomers of β-carotene have 
lower bioavailability than the all-E-isomers [14]. Furthermore, the results may depend on the 
evaluation method used. For instance, when the antioxidant activity of β-carotene was evalu-
ated based on oxidation of the low-density lipoprotein (LDL), the all-E-isomer showed higher 
antioxidant activity than the 9Z-isomer [17], whereas the 9Z-isomer showed higher antioxi-
dant activity when evaluated based on antiperoxidative activity [18]. Moreover, the beneficial 
effects of carotenoids differ between the Z-isomers. For example, when the antioxidant activ-
ity of fucoxanthin was evaluated in 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging 
activity assay, the order of activity was 13Z-isomer ≈ 13′Z-isomer > all-E-isomer > 9′Z-isomer 
[19]. The above findings indicate that a good understanding of the effects of E/Z-isomerization 
on functional changes is important for increasing the beneficial effects of carotenoid ingestion 
and for the industrial processing of carotenoids. The objective of this chapter is to highlight 
the impact of E/Z-isomerization of carotenoids on their bioavailabilities, antioxidant activities, 
Figure 1. Chemical structures of (A) (all-E)-lycopene, (B) (all-E)-β-carotene, (C) (all-E)-astaxanthin, (D) (all-E)-
fucoxanthin, (E) (9Z)-astaxanthin, and (F) (13Z)-astaxanthin.
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and inhibitory effects against diseases, such as atherogenesis and cancer. Furthermore, aspects 
of the change factor of the carotenoid bioavailability and functionality, modification of the 
physicochemical properties of carotenoids by E/Z-isomerization, and Z-isomerization meth-
ods used for carotenoids are also discussed in this chapter.
2. Effect of Z-isomerization of carotenoids on their bioavailabilities 
and functionalities
The effects of Z-isomerization on the bioavailability and functionality of eight carotenoids 
have been investigated thus far, including: (1) the bioavailability and antioxidant activity of 
lycopene; (2) the antioxidant activity of α-carotene; (3) the bioavailability and antioxidant, 
antiatherogenenic, and antiatherosclerotic activities of β-carotene; (4) the bioavailability and 
antioxidant activity of astaxanthin; (5) the antioxidant and pro-apoptotic activities of can-
thaxanthin; (6) the antioxidant and anticancer activities of fucoxanthin; (7) the bioavailability 
and antioxidant activity of lutein; and (8) the antioxidant activity of zeaxanthin. The changes 
caused by Z-isomerization varied according to the parental carotenoid molecules tested and 
the evaluation method employed. The findings are described in detail below.
2.1. Lycopene
Lycopene is an acyclic carotene (C
40
H
56
) that is principally responsible for the bright-red color 
found abundantly in vegetables and fruits such as tomatoes, guava, and watermelons [3, 9]. 
Lycopene shows an especially strong antioxidant activity among carotenoids [6] and can sig-
nificantly reduce the risks for arteriosclerosis, atherogenesis, and many types of cancer (such 
as prostate and esophageal cancer) [4, 5]. Therefore, in recent years, the use of lycopene in 
health foods and supplements, and as a natural functional pigment has attracted attention. It 
is well documented that the bioavailability and antioxidant activity of lycopene are changed 
by Z-isomerization. Most previous findings have demonstrated that the Z-isomerization of 
lycopene results in “positive” health effects.
Data from both in vitro and in vivo tests have suggested that Z-isomers of lycopene are more 
bioavailable than the all-E-isomer. Testing conducted using a diffusion model [20], bile acid 
micelles [21, 22], human intestinal Caco-2 cells [23], and lymph-cannulated ferrets [21, 22] has 
provided strong evidence supporting the higher bioavailability of the Z-isomers. Moreover, 
in humans, the ingestion of foods rich in lycopene Z-isomers resulted in a measurable increase 
in blood lycopene concentrations compared to a sample abundant in the (all-E)-isomer [12, 
24–27]. For example, Cooperstone et al. [12] investigated the effects of ingesting red tomato 
juice, which mainly contained (all-E)-lycopene (90% all-E-isomer) and tangerine tomato juice, 
which mainly contained Z-isomers of lycopene (94% Z-isomers), on plasma lycopene con-
centrations. Lycopene from the tangerine tomato juice showed approximately 8.5-fold greater 
bioavailability than lycopene from the red tomato juice. Unlu et al. [25] reported that when 
comparing two tomato sauces—one rich in all-E-lycopene (95% all-E-isomer) and the other 
rich in (Z)-lycopene (45% Z-isomers)—that the Z-isomer-rich tomato sauce was approximately 
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1.5 times more bioavailable than the all-E-isomer-rich sauce. In general, the uptake of carot-
enoids into intestinal mucosal cells is aided by the formation of bile acid micelles [21, 22, 24, 
27]. Thus, it is believed that because lycopene Z-isomers are more soluble in bile acid micelles 
than the all-E-isomer, they are preferentially incorporated into enterocytes and efficiently 
form chylomicrons [21, 22]. Indeed, very recently, several reports showed that the solubility of 
lycopene in oils, organic solvents, and supercritical CO
2
 (SC-CO
2
) was significantly improved 
by Z-isomerization [28–32]. However, Richelle et al. [33] showed by human oral-dosing tests 
that the (9Z)- and (13Z)-isomers were less efficiently absorbed than the 5Z- and all-E isomers 
or were converted into 5Z- and all-E isomers.
Several previous reports have shown that lycopene Z-isomers have higher antioxidant activ-
ity than the all-E isomer and that the relative activities of the isomers varied depending on 
the assay method [10, 11]. Böhm et al. [10] compared the antioxidant activity of (all-E)-lyco-
pene with four unknown Z-isomers by measuring their abilities to reduce radical cations of 
2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (TEAC assay), and each Z-isomer showed 
higher antioxidant activity than the all-E-isomer. Müller et al. [11] evaluated the antioxidant 
activities of (all-E)-, (5Z)-, (9Z)-, (13Z)-, and (7Z,9Z,7′Z,9′Z)-lycopene using four different in 
vitro assay, namely the TEAC assay, the ferric-reducing antioxidant power (FRAP) assay, the 
peroxyl radical-scavenging capacity (PSC) assay, and the heme-induced peroxidation of lin-
oleic acid in mildly acidic emulsions mimicking postprandial lipid oxidation in the gastric 
compartment (MbFeIII-LP) assay. No significant changes were observed among the isomers 
in the TEAC and FRAP assay. However, the lycopene Z-isomers showed higher antioxidant 
activities than the all-E isomer in the PSC assay (9Z-isomer > 5Z-isomer ≈ 7Z,9Z,7′Z,9′Z-isomer 
> 13Z-isomer > all-E-isomer) and in the MbFeIII-LP assay (5Z-isomer > all-E-isomer ≈ 9Z-isomer 
≈ 13Z-isomer ≈ 7Z,9Z,7′Z,9′Z-isomer). In TEAC assay, Böhm et al. [10] found that Z-isomers of 
lycopene had higher antioxidant activity, but Müller et al. [11] concluded that no significant 
differences occurred among the isomers. These discrepant findings may be explained by the 
fact that different concentrations of the isomers were used in each study [10, 11].
Based on the above findings, Z-isomerization effectively promotes the beneficial effects of 
lycopene. Among the Z-isomers, (5Z)-lycopene would have the highest bioavailability 
[33] and antioxidant activity [11]. Furthermore, the 5Z-isomer has the highest stability of 
the Z-isomers [34–36]. Therefore, regarding lycopene, it is very important to increase the 
5Z-isomer level and its ingestion. As the Z-isomerization method to increase (5Z)-lycopene 
efficiently, heating in some alkyl halides [37] and some kinds of oils such as sesame oil [9, 
38], light irradiation with photosensitizers [39], and catalytic treatment [20, 40] were effective. 
Moreover, to our best knowledge, because the effect of ingesting Z-isomer-rich lycopene on 
inhibiting the development of diseases such as atherogenesis and cancer has not been clari-
fied, further research in that field is expected in the future.
2.2. β-Carotene
β-carotene is a cyclic carotene (C
40
H
56
) that is found abundantly in vegetables and fruits, and 
provides vegetables such as carrots and pumpkins with a deep orange-yellow color [3, 4]. As 
with other carotenoids, β-carotene has a high antioxidant capacity [6] and preventive effect 
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against various diseases such as cancer and atherogenesis [4, 17]. Furthermore, β-carotene is 
very important as a retinol precursor, with a high conversion rate [3, 4]. It is also well docu-
mented that the bioavailability and antioxidant activity of β-carotene as well as its antiath-
erogenic activity are changed by Z-isomerization. Most previous studies have shown that 
the Z-isomerization results in “negative” effect for bioavailability. In contrast, β-carotene 
Z-isomerization has shown both “positive” and “negative” effects on antioxidant activity, 
depending on the evaluation method, and “positive” effects have been shown in terms of anti-
atherogenic activity.
Data from several in vitro and in vivo tests have indicated that Z-isomers of β-carotene are 
less bioavailable than the all-E-isomer. For example, in vivo tests using Caco-2 cells, HSC-T6 
cells, and liver microsomes [14], as well as in vivo tests using ferrets [41] and gerbils [42] have 
shown this phenomenon. In humans, the intake of Dunaliella salina and Dunaliella bardawil 
rich in (9Z)-β-carotene showed lower β-carotene bioavailability than foods rich in the all-
E-isomer [43–48]. The effects of the Z-isomer content on the bioavailability were opposite 
between lycopene and β-carotene. Generally, after carotenoids are extracted from the food 
matrix and incorporated into mixed micelles, bioaccessible carotenoids can be internalized 
by enterocytes [21, 22, 24, 27]. The main absorption site of carotenoids is in the duodenum, 
and several proteins that are temporarily present at the apical membrane mediate selectivity 
in terms of carotenoid uptake [27, 49–51]. In vitro experiments with Caco-2 cells showed that 
carotenoid transport decreased in the following order: β-carotene ≈ α-carotene (50% inhibi-
tion) > β-cryptoxanthin ≈ lycopene (20% inhibition) > lutein: zeaxanthin (1:1) (7% inhibition) 
[49]. Because carotenoid Z-isomers have higher solubility than the all-E-isomers [28–32], they 
can incorporate into bile acid micelles more efficiency [21, 22]. Therefore, it is considered that 
Z-isomers of β-carotene have lower transport efficiency in Caco-2 cell than the all-E-isomers 
[13]. However, a few studies have suggested that Z-isomers of β-carotene have higher bio-
availability than the all-E-isomers, as evaluated using human intestinal Caco-2 cells [52] and 
ferrets [53]. The use of different delivery systems with the cell model system and animal 
species might have caused discordant results [15].
Several studies have been conducted to compare the antioxidant activities of (all-E)-β-carotene 
and the Z-isomers, and the degree of antioxidant activity detected varied according to the 
assay method. Namely, the 9Z-isomer showed higher antioxidant activity than the all-E-iso-
mer when evaluated in terms of the sensitivity to external oxidants [54], the antiperoxidative 
activity [18], and oral dose testing in rats [55]. However, the opposite results (or no significant 
differences) were observed when the antioxidant activities were evaluated by measuring the 
oxidation of LDL [17] or in TEAC assay [10, 56], and PSC assay [56, 57]. Rodrigues et al. 
[57] reported that β-carotene Z-isomers were less efficient as peroxyl radical scavengers than 
the corresponding all-E-isomers: the Z-isomers presented the values about 20% lower than 
that found for the all-E-isomer, and they addressed that the negative effect may be due to 
the decreasing of the orbital overlap. Based on the above findings, it is difficult to conclude 
whether antioxidant activity is enhanced by Z-isomerization of the all-E-isomer.
Moreover, as additional “positive” effects of β-carotene Z-isomers, it has been reported 
that the 9Z-isomer has higher antiatherogenic activity [58] and antiatherosclerotic activity 
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[59, 60] than the all-E-isomer. On the other hand, there are other “negative” effects. Namely, 
β-carotene is a very important retinol precursor with a high conversion rate. The (all-E)- and 
(9Z)-β-carotene can be metabolized respectively to (all-E)-retinoic acid and (9Z)-retinoic acid 
[61, 62], both of which are active in gene regulation [63, 64]. However, the rates of cleavage 
of β-carotene isomers to vitamin A and the composition of the respective isomer metabolites 
vary, that is, (all-E)-β-carotene was the preferred substrate for cleavage to vitamin A when 
compared with the Z-isomers [61, 65, 66].
Regarding β-carotene, considering that “positive” and “negative” effects are associated with 
Z-isomerization, it is considered important to use them properly depending on the situation. 
Besides, as the Z-isomerization method for (all-E)-β-carotene, heating [67, 68], light irradiation 
with photosensitizers [69], and catalytic treatment [70, 71] were well documented. Moreover, 
Dunaliella salina and Dunaliella bardawil, which contain a large amount of (9Z)-β-carotene, 
have been used as Z-isomer-rich materials [43–48].
2.3. Astaxanthin
Astaxanthin is a xanthophyll (C
40
H
52
O
4
) that is principally responsible for the dark-red color 
in various microalgae and marine animals [1, 72]. Astaxanthin shows an especially strong 
antioxidant activity among carotenoids [6] and can significantly reduce the risk of cancer, eye 
disease, and cardiovascular disease [73, 74]. For instance, astaxanthin protected mice from 
carcinogenesis of the urinary bladder by reducing the incidence of chemically induced blad-
der carcinoma and further, astaxanthin supplementation in rats inhibited the stress-induced 
suppression of tumor-fighting natural killer cells [73]. In addition, astaxanthin is frequently 
used as an animal and fish feed additive to improve their body colors [75]. Data from several 
studies have demonstrated that the bioavailability and antioxidant activity of astaxanthin 
were changed by Z-isomerization.
In terms of the bioavailability, an in vitro test using a simulated digestion model and human 
intestinal Caco-2 cells [76] and human oral-dosing studies [16, 77] have shown that Z-isomers 
have higher bioavailability than the all-E-isomer. For example, Yang et al. [76] reported that 
(13Z)-astaxanthin showed higher bioaccessibility than (9Z)- and (all-E)-astaxanthins using an 
in vitro-digestion model, and (9Z)-astaxanthin exhibited higher cellular-transport efficiency 
than (all-E)- and (13Z)-astaxanthin in Caco-2 cell monolayers. However, oral-dosing stud-
ies in rainbow trout (Oncorhynchus mykiss) have shown a “negative” effect of astaxanthin 
Z-isomerization on bioavailability [78, 79]. These results suggest that the bioavailability of 
carotenoid isomers differs among species. Thus, future studies should seek to establish the 
biochemical basis for species-specific differences in the utilization of carotenoid isomers.
Although the antioxidant activity measured depends on the assay method employed, many 
studies have shown “positive” effects. Namely, assay that measure antioxidant enzyme 
activities, DPPH radical scavenging, oxygen radical-absorption capacity (ORAC), photo-
chemiluminescence (PLC) and peroxidation have shown higher antioxidant activities of 
astaxanthin Z-isomers than detected for the all-E-isomer [76, 80, 81]. In contrast, when the 
antioxidant activity was evaluated by a cellular antioxidant activity (CAA) assay, the order of 
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the antioxidant activity was 13Z-isomer > all-E-isomer > 9Z-isomer [81]. The results of these 
studies suggest that Z-isomers of astaxanthin, especially the 13Z-isomer, have higher antioxi-
dant activity than the all-E-isomer.
Most investigators have concluded that “positive” effects on the bioavailability and antioxi-
dant activity occurred following astaxanthin Z-isomerization. Thus, the ingestion of astax-
anthin Z-isomers could be effective in these terms. As with other carotenoids, Z-isomers of 
astaxanthin could be obtained by heating [81, 82] and catalytic treatment [76, 81, 83] of the 
all-E-isomer.
2.4. Canthaxanthin
Canthaxanthin is a xanthophyll (C
40
H
52
O
2
) that is principally responsible for the orange-
pink color found abundantly in egg yolk and various microbes such as Bradyrhizobium sp. 
and Halobacterium sp. [84, 85]. Canthaxanthin can significantly reduce the risk of cancer and 
neurodegenerative disorder [86, 87] and shows strong antioxidant activity [88], that is, can-
thaxanthin administration decreased mammary tumor volumes in mice [86] and exhibited 
antiinflammatory activities by increasing the activity of GPX and catalase, thereby reducing 
the production of IL-1, IL-6, and TNF-α [87]. Furthermore, canthaxanthin is widely used as 
feed for hens and fish to improve the egg yolk color and the body color, respectively [84, 
89]. A few reports have shown the effect of canthaxanthin Z-isomerization on antioxidant 
activity and functionality. Venugopalan et al. [88] reported that (9Z)-canthaxanthin isolated 
from Dietzia sp. had higher antioxidant activity, as evaluated by performing DPPH radical-
scavenging assay, superoxide radical-scavenging assay and fluorescence assay to detect 
reactive oxygen species generated in THP-1 cells. Moreover, the (9Z)-isomer exhibited higher 
pro-apoptotic activity than the all-E-isomer, which was evaluated in THP-1 macrophages [90]. 
The above literature indicates that Z-isomerization of canthaxanthin has “positive” effects. 
Canthaxanthin Z-isomerization can be achieved by heating and catalytic treatment [91, 92], 
and Dietzia sp. can serve as a source of (9Z)-canthaxanthin [88, 89].
2.5. Fucoxanthin
Fucoxanthin is an allenic xanthophyll (C
42
H
58
O
6
) that is found abundantly in edible shellfish 
and brown seaweeds such as Mactra chinensis and Undaria pinnatifida [1, 93]. Fucoxanthin 
has high antioxidant capacity [94] and shows anticancer and antiangiogenic activities [95, 
96]. For example, fucoxanthin remarkably reduced the viability of human colon cancer cell 
lines, such as Caco-2, HT-29, and DLD-1 cells [95]. In addition, fucoxanthin has antiobesity 
and antidiabetic effects [97–99], for example, administration of Wakame (Undaria pinnatifida) 
(which is rich in fucoxanthin) significantly suppressed body weight and white adipose tissue 
weight gain induced by the high fat diet in an obese murine model [98], which has attracted 
much attention recently in the food industry. The Z-isomerization of (all-E)-fucoxanthin can 
induce changes in the antioxidant and anticancer activities. Namely, Zhang et al. [19] reported 
that when the antioxidant activity of fucoxanthin isomers was evaluated by performing DPPH 
radical-scavenging and superoxide-detection assay, the following relative activities were 
observed: 13Z-isomer ≈ 13′Z-isomer > all-E-isomer > 9′Z-isomer. Evaluation by performing 
Effects of Z-Isomerization on the Bioavailability and Functionality of Carotenoids: A Review
http://dx.doi.org/10.5772/intechopen.78309
145
2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and hydroxyl radical-scaveng-
ing assay revealed the following relative activities: 9′Z-isomer > all-E-isomer >13Z-isomer ≈ 
13′Z-isomer. Moreover, Kawee-ai et al. [100] showed that when the ratio of the Z-isomer of 
fucoxanthin increased by 2% from 11 to 13% by heating, the scavenging activities against 
DPPH, hydrogen peroxide, and superoxide anions, and the reducing power decreased by 21.0, 
10.3, 16.0 and 19.7%, respectively. Hence, it is considered that the Z-isomerization of fucoxan-
thin negatively affects the antioxidant activity. However, Nakazawa et al. [13] demonstrated 
that Z-isomers of fucoxanthin had higher anticancer activity than the all-E-isomer, as evaluated 
by measuring the potent inhibitory effects on human promyelocytic leukemia cells (HL-60) and 
colon cancer cells (Caco-2). To the best of our knowledge, only fucoxanthin was investigated in 
terms of the effect of Z-isomerization on anticancer activity. Thus, it is expected that such inves-
tigation will extend to other carotenoids in the future. Z-isomerization of (all-E)-fucoxanthin 
has been achieved by heating and light irradiation [100, 101].
2.6. Lutein
Lutein is a xanthophyll (C
40
H
56
O
2
) that is principally responsible for the yellow-orange color 
found abundantly in vegetables, for example, corn, carrots, kale, and peas, and in egg yolks 
[102]. Lutein has preventive effects against various diseases such as eye diseases and cardio-
vascular diseases [102–104]. In particular, several studies have addressed the role of lutein 
in reducing the risk of the two most common eye diseases in older people, that is, cataracts 
and macular degeneration [102–104]. Only a few reports have shown the effect of lutein 
Z-isomerization on bioavailability and antioxidant activity [15, 105]. In vitro tests using a diges-
tion model have shown a higher bioaccessibility of Z-isomers of lutein than the all-E-isomer, 
and a Caco-2 cell monolayer model has shown a lower bioavailability. These results indicated 
that Z-isomers of lutein are more efficiently incorporated into bile acid micelles, but they have 
lower transport efficiency in enterocytes via the activities of carotenoid-transport proteins like 
β-carotene, as described above [15, 27, 49–51].
In terms of antioxidant activity, the Z-isomers, especially the 13′Z-isomer, have shown higher 
antioxidant activities than the all-E-isomer in FRAP, DPPH, and ORAC assay, but no sig-
nificant differences in the activities of the isomers were observed in CAA assay [15]. Since 
few reports are available regarding the effects of Z-isomerization on lutein bioavailability 
and functionality, and no such studies have been conducted in humans, further studies are 
needed to clarify whether Z-isomerization shows “positive” or “negative” effects. Several 
studies have reported that (all-E)-lutein can be isomerized to the Z-isomers by heating [106, 
107] and catalytic treatment [15].
2.7. Other carotenoids
The effects of Z-isomerization on the antioxidant activities of other carotenoids, such as 
α-carotene and zeaxanthin, were investigated by Böhm et al. [10] by performing TEAC 
assay. The following relative antioxidant activities of α-carotene stereoisomers were found: 
13′Z-isomer > all-E-isomer ≈ 9′Z-isomer > 9Z-isomer ≈ 13Z-isomer, whereas those for zeaxan-
thin were as follows: all-E-isomer ≈ 13Z-isomer > 9Z-isomer. It is difficult to discern whether 
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Carotenoid Evaluation Overview of results Effect* Reference
Lycopene Bioavailability/
bioaccessibility
Z-Isomers > all-E-isomer, evaluated using a diffusion 
model
+ [20]
Z-Isomers > all-E-isomer, evaluated using bile acid 
micelles and lymph-cannulated ferrets
+ [21, 22]
Z-Isomers > all-E-isomer, evaluated in Caco-2 cells + [23]
Z-Isomers > all-E-isomer, evaluated in human oral-dosing 
tests
+ [12, 24–26]
Antioxidant 
activity
Z-Isomers > all-E-isomer, evaluated in TEAC assay + [10]
Z-Isomers > all-E-isomer, evaluated in PSC and MbFeIII-LP 
assay
+ [11]
All-E-isomer ≈ Z-isomers, evaluated in TEAC and FRAP 
assay
± [11]
α-Carotene Antioxidant 
activity
13′Z-Isomer > all-E-isomer ≈ 9′Z-isomer > 9Z-isomer ≈ 
13Z-isomer, evaluated in TEAC assay
± [10]
β-Carotene Bioavailability/
bioaccessibility
All-E-isomer > Z-isomers, evaluated in Caco-2 cells, HSC-
T6 cells, and rat liver microsomes
− [14]
All-E-isomer > Z-isomers, evaluated in ferret oral-dosing 
test
− [41]
All-E-isomer > Z-isomers, evaluated in gerbil oral-dosing 
test
− [42]
All-E-isomer > 9Z-isomer, evaluated in human oral-dosing 
tests
− [43–48]
9Z-Isomer > all-E-isomer, evaluated in Caco-2 cells + [52]
9Z-Isomer > all-E-isomer, evaluated in the small intestines 
of ferrets
+ [53]
Antioxidant 
activity
9Z-Isomer > all-E-isomer, evaluated by measuring the 
sensitivity to external oxidants
+ [54]
9Z-Isomer > all-E-isomer, evaluated by determining the 
antiperoxidative activity
+ 18
9Z-Isomer > all-E-isomer, evaluated in rat oral-dosing tests + [55]
All-E-isomer > 9Z-isomer, evaluated by measuring LDL 
oxidation
− [17]
All-E-isomer ≈ 9Z-isomer ≈ 13Z-isomer ≈ 15Z-isomer, 
evaluated in TEAC assay
− [10]
All-E-isomer ≈ 9Z-isomer ≈ 13Z-isomer > 15Z-isomer, 
evaluated in TEAC and PSC assay
− [56,57]
Atherogenesis 
activity
9Z-Isomer > all-E-isomer, evaluated in knockout mice + [58]
Atherosclerosis 
activity
9Z-Isomer > all-E-isomer, evaluated in female LDLR−/− 
and apoE-deficient mice
+ [59, 60]
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Carotenoid Evaluation Overview of results Effect* Reference
Astaxanthin Bioavailability/
bioaccessibility
Z-Isomers > all-E-isomer, evaluated using a digestion 
model and Caco-2 cells
+ [76]
13Z-Isomer > all-E-isomer, 9Z-isomer, evaluated in human 
oral-dosing test
+ [77]
Z-Isomers > all-E-isomer, evaluated in human oral-dosing 
test
+ [16]
All-E-isomer > Z-isomers, evaluated in rainbow trout 
(Oncorhynchus mykiss) oral-dosing tests
− [78, 79]
Antioxidant 
activity
Z-Isomers > all-E-isomer, evaluated in antioxidant 
enzyme-activity assay
+ [76]
Z-Isomers > all-E-isomer, evaluated in DPPH and lipid-
peroxidation assay
+ [80]
Z-Isomers > all-E-isomer, evaluated in DPPH, ORAC, and 
PLC assay
+ [81]
13Z-Isomer > all-E-isomer >9Z-isomer, evaluated in CAA 
assay
± [81]
Canthaxanthin Antioxidant 
activity
9Z-Isomer > all-E-isomer, evaluated in DPPH, superoxide 
radical-scavenging, and fluorescence assay
+ [88]
Pro-apoptotic 
activity
9Z-Isomer > all-E-isomer, evaluated in THP-1 macrophages + [90]
Fucoxanthin Antioxidant 
activity
13Z-Isomer ≈ 13′Z-isomer > all-E-isomer > 9′Z-isomer, 
evaluated in DPPH and superoxide-detection assay
± [19]
9′Z-Isomer > all-E-isomer > 13Z-isomer ≈ 13′Z-isomer, 
evaluated in ABTS and hydroxyl radical-scavenging assay
± [19]
Z-Isomers > all-E-isomer, evaluated in DPPH, hydrogen 
peroxide-scavenging, superoxide anion, and reducing-
power assay
− [100]
Anticancer 
activity
Z-Isomers > all-E-isomer, evaluated in HL-60 cells and 
Caco-2 cells
+ [13]
Lutein Bioavailability/
bioaccessibility
Z-Isomers > all-E-isomer, evaluated using a digestion 
model
+ [15]
All-E-isomer > Z-isomers, evaluated in Caco-2 cells − [15]
13Z-Isomer > all-E-isomer, evaluated using a digestion 
model
+ [105]
Antioxidant 
activity
Z-Isomers > all-E-isomer, evaluated in FRAP assay + [15]
13′Z-Isomer > all-E-isomer ≈ 9Z-isomer, evaluated in 
DPPH and ORAC assay
+ [15]
All-E-isomer ≈ Z-isomers, evaluated in CAA assay ± [15]
Zeaxanthin Antioxidant 
activity
All-E-isomer ≈ 13Z-isomer > 9Z-isomers, evaluated in 
TEAC assay
− [10]
*Expected effect of carotenoid Z-isomerization on humans: +, “positive” effect; −, “negative” effect; ±, no change or 
indetermine.
Table 1. Summary of the effects of Z-isomerization of different carotenoids on the bioavailability and functionality.
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Z-isomers of both carotenoids have higher antioxidant activity than the all-E-isomer based 
on the TEAC assay results alone; thus, further evaluations by multiple testing methods are 
necessary.
To the best of our knowledge, the effect of Z-isomerization of other important carotenoids 
such as capsanthin and β-cryptoxanthin (which have large markets and high functionalities) 
on the bioavailability and functionality has not been reported. Among the over 1100 reported 
carotenoids found in nature, only the eight carotenoids mentioned above have been charac-
terized in terms of the effects of Z-isomerization, as summarized in Table 1. Thus, further 
progress in this research area is expected in the future.
3. Changes in the physicochemical properties of carotenoids by 
Z-isomerization
Changes in the bioavailability and functionality of carotenoids after Z-isomerization should 
have strong correlations with changes in their physicochemical properties. Several reports 
have shown that the Z-isomerization of carotenoids can induce changes in various properties 
such as the stability, solubility, and crystallinity. Some computational approaches using a 
Gaussian program have revealed that the Z-isomerization of carotenoids affected the Gibbs 
free energy [34, 35, 108, 109], that is, the relative stability of all-E- and mono-Z-isomers were 
in the following order: all-E-isomer ≈ 5Z-isomer > 9Z-isomer > 13Z-isomer > 15Z-isomer > 
7Z-isomer ≈ 11Z-isomer for lycopene [34, 35, 108]; all-E-isomer > 9Z-isomer > 13Z-isomer > 
15Z-isomer > 7Z-isomer ≈ 11Z-isome for β-carotene [109]. Thus, (all-E)-carotenoids should 
be more stable than the Z-isomers, which was confirmed experimentally by Murakami et al. 
[36] using lycopene isomers. Changes in the Gibbs free energy, stability, of carotenoids fol-
lowing Z-isomerization would affect their antioxidant activities. In addition, there is limited 
experimental evidence that the Z-isomers of carotenoids such as lycopene, β-carotene, and 
astaxanthin have higher solubility in vegetable oil, organic solvents and SC-CO
2
 than the all-
E-isomer [28–32, 110, 111], for example, the solubility of lycopene Z-isomers in ethanol was 
over 4000 times higher than that of the all-E-isomer [29]. These properties should affect the 
bioavailability of carotenoids. Namely, Z-isomerization of carotenoids could enhance uptake 
into bile acid micelles due to an increased solubility; thus, the bioavailability of lycopene and 
astaxanthin was improved [20–22]. On the other hand, regarding β-carotene and lutein, whose 
Z-isomers showed lower bioavailability [15, 41–48, 105], the uptake into bile acid micelles 
could potentially be improved by Z-isomerization, but they might have lower transport effi-
ciency in enterocytes due to the activities of several carotenoids transport proteins, which are 
temporarily present at the apical membrane [27, 49–51]. In vitro tests of lutein support this 
hypothesis, that is, the Z-isomers showed higher bioaccessibility than the all-E-isomers in a 
digestion model [15, 105], whereas the opposite result was obtained in Caco-2 cells [15]. It has 
been predicted that Z-isomers of lycopene and astaxanthin can be efficiently internalized via 
carotenoid transporters, based on the results of testing conducted using Caco-2 cells [23, 76]. 
The abovementioned theory is strongly supported by the observations that, in human blood, 
over 50% of total lycopene exists in the Z-form, but only 5% of total β-carotene exists in the 
Z-form [112]. To attain a better understanding of the underlying mechanisms, further study 
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on the uptake process of (Z)-carotenoids in enterocytes by carotenoid transport proteins is 
necessary. Furthermore, the crystallinity of carotenoids was changed by Z-isomerization: 
although (all-E)-carotenoids existed in a crystalline state, the Z-isomers were in an amor-
phous state, which was confirmed by optical observations, differential scanning calorimetry, 
powder X-ray diffraction, and scanning electron microscopy analyses [20, 28, 29, 113]. The 
change in crystallinity resulting from Z-isomerization may also influence changes in carot-
enoid bioavailability and functionality.
4. Conclusions
Z-Isomerization of carotenoids can cause changes in the bioavailability, antioxidant activity, 
and other functionalities (such as anticancer and antiatherogenic activities), and it may result 
in “positive” or “negative” effects, which vary according to the type of carotenoid. Although 
more than 1100 carotenoids are found in nature, only the eight carotenoids discussed above 
have been investigated in terms of these effects. Thus, further progress in this research area is 
expected. Furthermore, most investigations have focused on the effects of Z-isomerization of 
carotenoids on the bioavailability and antioxidant activity, but the Z-isomerization has been 
shown to enhance the anticancer and antiatherogenic activities of β-carotene and fucoxanthin. 
Since these data provide important evidence for the roles of carotenoid Z-isomerization in 
human health, examination of other carotenoids is expected in the future.
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